Statistics
Publications
190
Citations
19.1K
H-Index
70
Active since
1998
Rema Raman is an author at University of California San Diego specializing in medicine, neurology, and dementia.
Publications per year
1998–2025
190
190
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text
Medicine, Neurology, Neuroscience +14
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease
Gorazd B. Stokin, Concepción Lillo, Tomás L. Falzone et al. · Science · 2005 · 1.2K citations
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Rachelle S. Doody, Rema Raman, Martin R. Farlow et al. · New England Journal of Medicine · 2013 · 1.2K citations
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease
Joseph F. Quinn, Rema Raman, Ronald G. Thomas et al. · JAMA · 2010 · 753 citations
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Raymond Scott Turner, Ronald G. Thomas, Suzanne Craft et al. · Neurology · 2015 · 699 citations · Full text
Medicine, Neurology, Neuroscience +15
1–5 of 190